Cargando…
Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
Scope: Bleeding, the main drawback of clinically used chemical anti-thrombotic drug is resulted from the unidirectional suppression of platelet activity. Therefore, dual-directional regulatory effect on platelet is the main preponderance of Panax notoginseng over these drugs. The dual-directional re...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232503/ https://www.ncbi.nlm.nih.gov/pubmed/30459626 http://dx.doi.org/10.3389/fphar.2018.01293 |
_version_ | 1783370402847784960 |
---|---|
author | Liu, Yingqiu Liu, Tianyi Ding, Kevin Liu, Zengyuan Li, Yuanyuan He, Taotao Zhang, Weimin Fan, Yunpeng Ma, Wuren Cui, Li Song, Xiaoping |
author_facet | Liu, Yingqiu Liu, Tianyi Ding, Kevin Liu, Zengyuan Li, Yuanyuan He, Taotao Zhang, Weimin Fan, Yunpeng Ma, Wuren Cui, Li Song, Xiaoping |
author_sort | Liu, Yingqiu |
collection | PubMed |
description | Scope: Bleeding, the main drawback of clinically used chemical anti-thrombotic drug is resulted from the unidirectional suppression of platelet activity. Therefore, dual-directional regulatory effect on platelet is the main preponderance of Panax notoginseng over these drugs. The dual-directional regulatory effect should be ascribed to the resourceful Panax notoginseng saponins (PNS). Clarifying the mechanism of main PNS in both inhibiting and promoting platelet aggregation will give a full outlook for the dual-directional regulatory effect. The present study is aimed at explaining the mechanism of Notoginsenoside Fc (Fc), a main PNS, in inhibiting platelet aggregation. Methods: In the in vitro study, after incubating platelets with Fc and m-3M3FBS, platelet aggregation was triggered by thrombin, collagen or ADP. Platelet aggregation was measured by aggregometer. Phospholipase Cγ2 (PLCγ2) and protein kinase C (PKC) activities were studied by western blotting. Diacylglycerol (DAG), thromboxane B(2) (TXB(2)) and 1,4,5-inositol trisphosphate (IP(3)) concentrations were measured by corresponding ELISA kits. Calcium concentrations ([Ca(2+)]) were estimated through the fluorescence intensity emitted from Fluo-4. In the in vivo study, thrombus model was induced by FeCl(3). The effect of Fc on thrombosis was evaluated by measurement of protein content and observation of injured blood vessel. Results: thrombin, collagen and ADP induced platelet aggregation were all suppressed by incubating platelets with Fc. Platelet PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3) were down-regulated by Fc as well. However, the basal [Ca(2+)] in platelet was not altered by Fc. Nevertheless, thrombin triggered activation of PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3)-[Ca(2+)] were all abolished by Fc. Fc also attenuated platelet aggregation and PLCγ2 signaling activation induced by PLC activator, m-3M3FBS. In the in vivo study, FeCl(3) induced thrombosis in rat femoral artery was significantly alleviated by administration of Fc. Conclusion: The results above suggested the antiplatelet and antithrombotic effects of Fc are carried out through oppression of PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3)-[Ca(2+)]. The present study provided theoretical support for new anti-thrombotic drug exploitation by Panax notoginseng. |
format | Online Article Text |
id | pubmed-6232503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62325032018-11-20 Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc Liu, Yingqiu Liu, Tianyi Ding, Kevin Liu, Zengyuan Li, Yuanyuan He, Taotao Zhang, Weimin Fan, Yunpeng Ma, Wuren Cui, Li Song, Xiaoping Front Pharmacol Pharmacology Scope: Bleeding, the main drawback of clinically used chemical anti-thrombotic drug is resulted from the unidirectional suppression of platelet activity. Therefore, dual-directional regulatory effect on platelet is the main preponderance of Panax notoginseng over these drugs. The dual-directional regulatory effect should be ascribed to the resourceful Panax notoginseng saponins (PNS). Clarifying the mechanism of main PNS in both inhibiting and promoting platelet aggregation will give a full outlook for the dual-directional regulatory effect. The present study is aimed at explaining the mechanism of Notoginsenoside Fc (Fc), a main PNS, in inhibiting platelet aggregation. Methods: In the in vitro study, after incubating platelets with Fc and m-3M3FBS, platelet aggregation was triggered by thrombin, collagen or ADP. Platelet aggregation was measured by aggregometer. Phospholipase Cγ2 (PLCγ2) and protein kinase C (PKC) activities were studied by western blotting. Diacylglycerol (DAG), thromboxane B(2) (TXB(2)) and 1,4,5-inositol trisphosphate (IP(3)) concentrations were measured by corresponding ELISA kits. Calcium concentrations ([Ca(2+)]) were estimated through the fluorescence intensity emitted from Fluo-4. In the in vivo study, thrombus model was induced by FeCl(3). The effect of Fc on thrombosis was evaluated by measurement of protein content and observation of injured blood vessel. Results: thrombin, collagen and ADP induced platelet aggregation were all suppressed by incubating platelets with Fc. Platelet PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3) were down-regulated by Fc as well. However, the basal [Ca(2+)] in platelet was not altered by Fc. Nevertheless, thrombin triggered activation of PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3)-[Ca(2+)] were all abolished by Fc. Fc also attenuated platelet aggregation and PLCγ2 signaling activation induced by PLC activator, m-3M3FBS. In the in vivo study, FeCl(3) induced thrombosis in rat femoral artery was significantly alleviated by administration of Fc. Conclusion: The results above suggested the antiplatelet and antithrombotic effects of Fc are carried out through oppression of PLCγ2 and subsequent DAG-PKC-TXA(2) and IP(3)-[Ca(2+)]. The present study provided theoretical support for new anti-thrombotic drug exploitation by Panax notoginseng. Frontiers Media S.A. 2018-11-06 /pmc/articles/PMC6232503/ /pubmed/30459626 http://dx.doi.org/10.3389/fphar.2018.01293 Text en Copyright © 2018 Liu, Liu, Ding, Liu, Li, He, Zhang, Fan, Ma, Cui and Song. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Liu, Yingqiu Liu, Tianyi Ding, Kevin Liu, Zengyuan Li, Yuanyuan He, Taotao Zhang, Weimin Fan, Yunpeng Ma, Wuren Cui, Li Song, Xiaoping Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc |
title | Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc |
title_full | Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc |
title_fullStr | Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc |
title_full_unstemmed | Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc |
title_short | Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc |
title_sort | phospholipase cγ2 signaling cascade contribute to the antiplatelet effect of notoginsenoside fc |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232503/ https://www.ncbi.nlm.nih.gov/pubmed/30459626 http://dx.doi.org/10.3389/fphar.2018.01293 |
work_keys_str_mv | AT liuyingqiu phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT liutianyi phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT dingkevin phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT liuzengyuan phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT liyuanyuan phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT hetaotao phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT zhangweimin phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT fanyunpeng phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT mawuren phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT cuili phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc AT songxiaoping phospholipasecg2signalingcascadecontributetotheantiplateleteffectofnotoginsenosidefc |